Artificial Intelligence | Machine Learning Ligence | Tool for Automated Echocardiography


Enterprise, Echocardiography, Healthcare, Computer Software, Deep Learning, Data Collection & Analytics Kaunas, Kauno Apskritis, Lithuania

Ligence

Artificial Intelligence | Machine Learning


Ligence | Tool for Automated Echocardiography

Ligence

Echocardiography, Healthcare, Computer Software, Deep Learning, Data Collection & Analytics


Kaunas, Kauno Apskritis, Lithuania

Ligence - AI Startup | AI Startup Profile Powered by Appengine AI | Appengine AI - World's Most Promising AI Startups & AI Ecosystem of 10,000+ AI Startups appengine.ai Get Started

Cardiac ultrasound is a safe and inexpensive test for monitoring and preventing heart disease. Manual work (e.g. measuring, writing report) takes 50-85% of test time. We make cardiac ultrasound more accessible, cheaper, and less human-reliant by automating the analysis.

We are a team of medical doctors who also happen to know AI and thus we build exciting solutions for healthcare. Our latest project is the automation of heart ultrasound image analysis using Deep Learning algorithms. The product we call CardioEchoAI is able to automatically recognize heart image view and perform all the necessary measurements. We developed software for the automated heart ultrasound imaging workflow that allows reducing the average examination time by ~85%, i.e. from 30 to 5 min, and increase the overall accuracy. This increases patient admission 6 times and increases revenue by more than 2M (by one cardiologist).

 
 

   Total Funding: $458,780

   Funding Stage: Funded

   Business Stage: Scaling Up

   Market: B2B

   Company Size: 1 to 25

   Founded: 2019

 
 
 
 
Arnas Karužas


Arnas Karužas
CEO

Dovydas Matuliauskas


Dovydas Matuliauskas
CFO & co-founder

Justinas


Justinas
COO

 
 

Ligence is growing. Want to work at Ligence? Ligence is hiring. Join team at Ligence

 
 
appengine.ai

World's Most Promising AI Startups





World's Leading AI Ecosystem of AI Startups, Founders, Investors, and AI Professionals


Get Started